U.S. markets open in 9 hours 26 minutes

II-VI Incorporated (IIVI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
71.67-2.94 (-3.94%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close74.61
Bid71.26 x 900
Ask72.49 x 900
Day's Range71.13 - 76.17
52 Week Range19.00 - 100.44
Avg. Volume1,483,210
Market Cap7.508B
Beta (5Y Monthly)1.56
PE Ratio (TTM)39.97
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Coherent Determines Revised Buyout Offer From II-VI To Be Financially Best Fit

    Coherent Determines Revised Buyout Offer From II-VI To Be Financially Best Fit

    Coherent, the provider of lasers and laser-based technologies, deemed the revised buyout offer from II-VI Incorporated as a “Company Superior Proposal.” Per the terms of the revised proposal, the manufacturer of engineered materials and optoelectronic components will pay $170 in cash and 1.0981 shares of II-VI for each share of Coherent (COHR). Coherent intends to terminate the merger agreement with California-based manufacturer and seller of optical and photonic products, Lumentum Holdings (LITE), entered into this January. The company has said the same to Lumentum unless Coherent receives a favorable revised proposal from Lumentum by March 11, 2021. Coherent previously agreed to be acquired for $100 in cash and 1.1851 shares of Lumentum common stock for each share of Coherent. Further, it received two revised proposals from Lumentum. Under the first proposal, each share of Coherent common stock was offered to be exchanged for $175 in cash and 1.0109 shares of Lumentum common stock, while the other proposal offered $170 in cash and 1.0109 shares of Lumentum common stock. Both proposals also included a significantly higher termination fee for accepting competing acquisition proposals. (See Coherent stock analysis on TipRanks) Last month, Coherent also received an unsolicited acquisition proposal from MKS Instruments, in which each share of Coherent common stock was offered to be exchanged for $115 in cash and 0.7473 per share of MKS (MKSI) common stock. Further, MKSI’s revised proposal offered each share of Coherent common stock to be exchanged for $135 in cash and 0.7516 of a share of MKS common stock. Therefore, after a thorough review of all proposals, the company’s board of directors, in consultation with financial and legal advisors, unanimously determined II-VI’s (IIVI) revised acquisition proposal to be the best fit. On Feb. 11, Benchmark Co. analyst Mark Miller downgraded the rating to Hold from Buy on the stock. Meanwhile, the consensus rating on the stock is a Hold. That’s based on unanimous 6 Holds. Looking ahead, the average analyst price target stands at $210.33, putting the downside potential at about 10.6% over the next 12 months. Shares jumped 88.6% over the past year. Related News: Big Lots’ 4Q Profit Beats Analysts’ Estimates As Comparable Sales Rise; Shares Gain 2% Amgen Inks $1.9B Deal To Buy Five Prime Therapeutics; Shares Pop 79% TopBuild Buys Insulation Peer Ozark Foam; Street Sees 16% Upside More recent articles from Smarter Analyst: Paya’s 4Q Revenues Outperform Estimates; Street Is Bullish Monday’s Pre-Market: Here’s What You Need To Know Before The Market Opens Sigilon’s SIG-007 Granted Orphan Drug Designation By FDA; Shares Pop 6% Gilead’s Kite Receives FDA Approval For Yescarta Immunotherapy; Street Sees 17% Upside

  • TheStreet.com

    MKS Drops Bid for Laser-Tech Producer Coherent

    MKS Instruments said on Monday that it was abandoning its quest to buy laser-technology company Coherent . The decision came after Coherent chose a proposal to be acquired by II-VI IIVI, which makes engineered materials. Coherent also set a deadline by which Lumentum must at least match II-VI's proposal.

  • Lumentum has 4 days to match II-VI's rival buyout bid for Coherent

    Lumentum has 4 days to match II-VI's rival buyout bid for Coherent

    Lumentum Holdings Inc. said Monday it received notice from laser technology company Coherent Inc. , which Lumentum has entered into an agreement to acquire, that the unsolicited buyout bid it received from II-VI Inc. was "superior." Lumentum said it will review the II-VI bid, and will have four days to match the rival bid. if the Lumentum-Coherent merger agreement is terminated, Coherent will be required to pay a $217.6 million termination fee. On Feb. 12, II-VI made a $260-per-share cash-and-stock bid to buy Coherent, valuing the company at the time at $6.36 billion, while the cash-and-stock merger agreement with Lumentum announced on Jan. 19 was valued at $5.7 billion. Lumentum's stock gained 0.1% in premarket trading while Coherent's stock rallied 4.4% and II-VI share shed 2.8%. Meanwhile, futures for the S&P 500 fell 0.5%.